Howard Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$769K Sell
641
-6
-0.9% -$6.13K 0.28% 68
2026
Q1
$596K Buy
647
+15
+2% +$15.2K 0.25% 77
2025
Q4
$680K Sell
632
-5
-0.8% -$4.78K 0.3% 69
2025
Q3
$486K Sell
637
-19
-3% -$14.1K 0.22% 81
2025
Q2
$511K Sell
656
-9
-1% -$6.99K 0.26% 78
2025
Q1
$549K Buy
665
+7
+1% +$5.83K 0.31% 72
2024
Q4
$508K Buy
658
+5
+0.8% +$4.14K 0.28% 72
2024
Q3
$578K Buy
653
+4
+0.6% +$3.6K 0.34% 65
2024
Q2
$588K Hold
649
0.46% 53
2024
Q1
$505K Buy
+649
New +$462K 0.41% 54
2020
Q1
Sell
-650
Closed -$85K 319
2019
Q4
$85K Buy
+650
New +$75.3K 0.07% 148

Other funds holding LLY

Howard Wealth Management's LLY Position: Q2 2026 in Review

Howard Wealth Management reduced its Eli Lilly (LLY) stake by 0.93% in Q2 2026, selling an estimated $6.13K and leaving 641 shares worth $769K. The position accounts for 0.28% of the portfolio, ranked #68.

Howard Wealth Management first reported a position in LLY in Q4 2019 and has held it in 11 quarters since. 1,691 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Howard Wealth Management held 641 shares of Eli Lilly worth $769K as of Q2 2026.
  • Howard Wealth Management sold 6 Eli Lilly shares in Q2 2026, an estimated $6.13K.
  • Eli Lilly made up 0.28% of Howard Wealth Management's portfolio in Q2 2026, its #68 holding.
  • Howard Wealth Management first reported a position in Eli Lilly in Q4 2019 and has held it in 11 quarters since.
  • 1,691 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Howard Wealth Management's 13F filing for Q2 2026, filed 21 Jul 2026.